Objective: The influence of endovascular aneurysm repair (EVAR) on renal function is of high concern. The question whether stent graft fixation type plays a significant role in renal outcome after EVAR is still debated. However, other factors, such as repeated contrast medium exposure, should also be considered.
Renal impairment is one of the major concerns in endovascular aneurysm repair (EVAR). [1] [2] [3] A metaanalysis by Karthikesalingam et al 4 showed that renal deterioration after EVAR is common and underreported in the literature. The impact of infrarenal (IR) or suprarenal (SR) fixation of abdominal endografts on renal function has been debated, and there has been no prospective randomised trial comparing the two options. Although the SR landing zone may be of advantage to avoid migration, the crossing of the renal ostium with bare metal stents raises the theoretical risk for renal infarction or deterioration. A recently published review of the available literature by Miller et al 5 showed no significant difference in renal function for either type of endograft fixation but emphasizes several limitations in their analysis. The majority of the included studies used first-generation stent grafts. 6, 7 The study populations were usually small with heterogeneous measurements of renal function and inconsistent follow-up. 7, 8 Other factors influencing renal impairment, such as the intraoperative and follow-up use of contrast medium, were missing in several of the included studies. 5 To overcome the limitations of the current literature, a two-arm case control study was conducted to evaluate the influence of last-generation abdominal endografts with SR vs IR fixation on renal function.
METHODS
Patients included in the study were treated in two highvolume European vascular centers with advanced experience with EVAR for IR abdominal aortic aneurysms In center B, all IR AAAs (n ¼ 557) were treated with stent grafts with SR fixation such as the Endurant II (Medtronic, Santa Rosa, Calif). Patients from center B treated within the IFU for the Endurant II stent graft were matched to the cohort of center A using stratification for demographics (age and sex) and preoperative renal function to create a homogenous study cohort. To have similar preoperative and postoperative renal protection protocols between the two centers, only patients treated after 2012 were stratified from center B. After stratification, 142 patients from center B were included in the study (Fig) . Because of the retrospective nature of the study and anonymization of the data, no informed consent of the patients was required according to our Institutional Review Board.
Statistical analysis was done using IBM SPSS Statistics software for Windows release 22 (SPSS Inc, Chicago, Ill). As the samples were normally distributed (using Kolmogorov-Smirnov test), the parametric tests were used. Differences of continuous variables between two study groups were proven using independent samples t-test and within the groups using pair samples t-test.
The c 2 test following Pearson and the exact Fisher test were used to compare the relationships between two categoric variables. A P value of <.05 was considered statistically significant.
Evaluation of renal function. We assessed the preoperative, the postoperative (highest postoperative measured level until hospital discharge), and the 12-month followup serum creatinine levels. Twelve-month follow-up serum creatinine level was assessed at follow-up visit prior to the scheduled computed tomography (CT) scan. Serum creatinine was measured in each clinic's laboratory; unit for serum creatinine was mg/dL in both laboratories. Using the Chronic Kidney Disease Epidemiology Collaboration formula, the preoperative, postoperative, and 12-month follow-up eGFRs were calculated to estimate the renal function. In addition, we evaluated the intraoperatively used amount of contrast medium as well the postoperative application of contrast medium during postoperative CT scans and interventions using contrast medium in the 12-month follow-up. Regarding the postoperative creatinine value, we used the highest measured value for each patient until hospital discharge. A preoperative renal insufficiency was defined as an eGFR #60 mL/min. We defined a postoperative renal impairment as a decrease of postoperative or 12-month follow-up eGFR of 20% or more compared with baseline eGFR.
For comparable postoperative follow-up, we performed a subanalysis of patients having only one postoperative CT scan and no alternative contrast medium exposure (eg, reintervention, coronary artery intervention) during the first 12 months.
RESULTS
Patients enrolled in the two groups A and B (overall, n ¼ 276; group A, n ¼ 134; group B, n ¼ 142) showed no significant difference regarding age, sex, and maximum aneurysm diameter (Table I) . Most patients were male group A, 91.8% (123/134) and group B, 88.0% (125/142). There was also no significant difference in the intraoperative use of contrast medium with a mean of 120 mL for group A and 105 mL for group B. The preoperative eGFR was also comparable (Tables I and II) . Mean postoperative hospital stay was 5.0 days in center A (range, 2-22 days) and 6.0 days (range, 2-18 days) in center B. No patient was discharged on the first postoperative day. In both centers, all patients with preoperative renal insufficiency or postoperative increase of serum creatinine were not discharged before the third postoperative day and only after reaching a plateau or showing a decrease of serum creatinine.
Renal function. There was no intended or accidental coverage of a renal artery in either of the groups. One patient with a preoperative eGFR of 15.5 mL/min from center A had a new onset hemodialysis 10 months after EVAR. Overall, 11.2% of the patients (31/276) showed a relevant decline ($20%) of eGFR postoperatively and 11.5% (31/269) after 12 months with a mean 12-month decrease of eGFR of 2.31 mL/min/1.73 m 2 .
In group A, 19/134 (14.2%) patients and in group B, 12/142 (8.5%) patients showed a decrease of eGFR $20% in the results for postoperative renal impairment between the two groups, but this difference was not significant (P ¼ .132). Comparing the 12-month follow-up, there was also no significant difference between the two groups (group A, n ¼ 18/134; group B, n ¼ 13/135; P ¼ .329) ( Table III) .
The subgroup analysis for patients with a good preoperative renal function (eGFR >60 mL/min) and patients with a preoperative renal insufficiency (eGFR #60 mL/ min) showed no significant difference for IR vs SR fixation in either group (Tables IV and V) . We evaluated the influence of contrast medium application in a subgroup analysis of the patients with only one postoperative CT scan and no other contrast medium exposure (eg, caused by reintervention, coronary angiography) within the 12-month follow-up. Overall, four of the 102 patients (3.9%) included in this subgroup analysis had eGFR decrease of $20% at 12 months (Table VI ) (35 patients from group A vs 67 patients from group B). One out of the 35 (2.9%) with IR fixation (group A) and three of the 67 (4.5%) with SR fixation (group B) showed a decline in eGFR values of $20% at 12 months (P ¼ 1.0). On the other hand, these patients with only one CT in the follow-up (n ¼ 102) showed significantly less renal impairment (4/102; 3.9%) than the rest of the study collectively (>1 CT scan/ þ1 or more interventions with contrast medium) (27/166; 16.9%) (P ¼ .002).
DISCUSSION
The present study demonstrates no significant difference in postoperative renal function between IR and SR fixation in patients treated with EVAR for IR AAA. Renal impairment was analyzed by using the eGFR, which is more sensitive than serum creatinine. 9 EVAR was associated with renal function deterioration in 11.2% of the patients postoperatively during hospitalization and in 11.5% of the patients 1 year after EVAR. This was independent of the type of fixation but dependent on the amount of contrast medium exposure. Moreover, there was a significantly worse outcome in renal function after 12 months in patients who had more than one CT scans compared with patients with only one CT scan within the follow-up. In detail, in patients with only one postoperative CT scan and no other contrast medium exposure caused by reintervention, only 4/102 (3.9%) showed a decrease of $20% in eGFR after 12 months. This is consistent with the fact that iodine based contrast agents are one of the leading causes for acute kidney injury. 10, 11 A study by Abaci et al 12 showed, that patients with preexisting renal dysfunction have high risk of renal failure requiring dialysis in the long-term follow-up after contrast medium exposure, even if they do not experience contrast induced acute kidney injury compared with patients with no exposure to iodine contrast medium. This could be of major concern when planning the follow-up protocol after EVAR. Contrast medium exposure and, thus, continued renal deterioration can be avoided by using alternative procedural imaging such as contrast-enhanced duplex ultrasound or magnetic resonance imaging (MRI) for EVAR surveillance. A series of studies have shown that contrast-enhanced duplex ultrasound is equal to contrast-enhanced CTimaging for detection and characterization of endoleaks in EVAR follow-up. 13, 14 The Excluder (W. L. Gore and Associates), as well as the Endurant II (Medtronic) stent graft, is MRI compatible; several studies have shown that contrast-enhanced MRI is a comparable alternative to contrast-enhanced CT for the detection of endoleaks and rarely affects renal function. 15, 16 However, these studies did not investigate the renal function over time; therefore, a prospective comparative study on the renal function after the different postoperative surveillance protocols is needed to give a more robust answer. Durability of EVAR depends on secure proximal fixation of the stent graft. Fixation may be possible by hooks and barbs as well as by uncovered portions of the proximal stent. [17] [18] [19] [20] Different groups have demonstrated the feasibility of renal stent jail in human beings without compromising various renal function tests. 17, 18, [21] [22] [23] A published summary about the midterm results of the Zenith endovascular system (Cook Medical Inc, Bloomington, Ind) stated the security over a mean of 14 months of follow-up. Although renal complications were noted periprocedurally in just over 7% of the population, there were no significant changes during the follow-up regarding blood urea nitrogen levels or the serum creatinine levels. There were no renal complications attributed to the placement of the SR stent.
19 Nevertheless, our study has limitations. First, because of the retrospective design, randomization was not possible. Then, we compared patients over a longer time period from one center (2005 until 2013) with more recent patients from the other center (2013 and 2014). The latter had an active study protocol until 2012 with the use of indometacin for renal protection for all patients with EVAR. These patients were excluded because of a potential bias. Unfortunately, the amount of intraoperatively used contrast medium was not available for all patients from center A; for those available, there was no significant difference in intraoperative contrast medium use in both centers.
Also, during the examined time period, the intraoperative use of contrast medium could be reduced because of intraoperative vessel navigation systems; the amount of postoperative CT scans was reduced to a minimum in the more recently treated patients. To reduce the bias resulting in this difference, we performed the subgroup analysis with patients who had only one postoperative CT scan. This subgroup analysis also showed no difference between the two groups. These results are consistent with the more current literature. 5 Lastly, our study investigated the changes of renal function after EVAR in the first postoperative year. Studies with longer follow-up are necessary to evaluate renal impairment in the long term but confounding factors such as age, comorbidities with influence on renal function, as well as very heterogeneous contrast medium exposure in patients with abdominal aneurysm disease could significantly influence the results.
CONCLUSIONS
In similar patient cohorts, there is no significant difference in renal impairment for SR or IR fixation in EVAR for IR AAA. The use of modern generation stent grafts with either SR or IR fixation is safe when performed by EVAR-experienced centers and has a low rate of persistent renal deterioration after 12 months. However, our analysis showed that increased contrast medium exposure led to significant renal deterioration after 12 months. An increased exposure of contrast medium during the follow-up is of concern, thus, alternative imaging with less influence on renal function such as contrastenhanced duplex ultrasound or MRI for EVAR surveillance should be considered.
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